<!doctype html><html lang=en-us><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=generator content="Wowchemy 5.7.0 for Hugo"><link rel=stylesheet href=/css/vendor-bundle.min.16f785cdb553c8c4431db6775122af35.css media=print onload='this.media="all"'><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/academicons@1.9.2/css/academicons.min.css integrity="sha512-KlJCpRsLf+KKu2VQa5vmRuClRFjxc5lXO03ixZt82HZUk41+1I0bD8KBSA0fY290ayMfWYI9udIqeOWSu1/uZg==" crossorigin=anonymous media=print onload='this.media="all"'><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/leaflet@1.7.1/dist/leaflet.min.css integrity crossorigin=anonymous media=print onload='this.media="all"'><link rel=stylesheet href=/css/wowchemy.5928d6f6b5eee121dc6141d2cdd0af46.css><link rel=stylesheet href=/css/libs/chroma/github-light.min.css title=hl-light media=print onload='this.media="all"'><link rel=stylesheet href=/css/libs/chroma/dracula.min.css title=hl-dark media=print onload='this.media="all"' disabled><meta name=author content="Christian Brueffer"><meta name=description content="**Background**<br />
Breast cancer is a disease of genomic alterations, of which the complete panorama of somatic mutations and how these relate to molecular subtypes and therapy response is incompletely understood. The Sweden Cancerome Analysis Network-Breast project (SCAN-B; ClinicalTrials.gov NCT02306096) is a multi-center population-based ongoing prospective observational study elucidating the global transcriptomic profiles for thousands of patients and tumors using RNA sequencing. Since September 2010, over 15,000 patients with breast cancer have been enrolled at 9 hospitals across a wide geography of Sweden, comprising greater than 90% of all eligible patients in the catchment area.<br />
**Methods**<br />
Within SCAN-B, we developed an optimized bioinformatics pipeline for detection of single nucleotide variants and small insertions and deletions from RNA-seq data. From this, we describe the mutational landscape of 3,217 primary breast cancer transcriptomes, and relate it to patient overall survival in a real-world setting (median follow-up 75 months, range 2-105 months).<br />
**Results**<br />
We demonstrate that RNA-seq can be used to call mutations in important breast cancer genes such as *PIK3CA*, *TP53*, *ESR1*, and *ERBB2*, as well as mutation status of key molecular pathways and tumor mutational burden, identify mutations in one or more potentially druggable genes in 85.3% percent of cases, and reveal significant relationships to patient outcome within specific treatment groups. To make this rich and growing mutational portraiture of breast cancer available for the wider research community, we developed an open source interactive web application, SCAN-B MutationExplorer, publicly accessible at http://oncogenomics.bmc.lu.se/MutationExplorer.<br />
**Conclusions**<br /> These results add another dimension to the use of RNA-seq as a potential clinical tool, where both gene expression-based signatures and gene mutation-based biomarkers can be interrogated simultaneously and in real-time within one week of tumor sampling."><link rel=alternate hreflang=en-us href=https://www.brueffer.io/publication/2020_asco/><link rel=canonical href=https://www.brueffer.io/publication/2020_asco/><link rel=manifest href=/manifest.webmanifest><link rel=icon type=image/png href=/media/icon_hu7422bdd1ad1d5b8840d6088d6ba7ed4c_15338_32x32_fill_lanczos_center_3.png><link rel=apple-touch-icon type=image/png href=/media/icon_hu7422bdd1ad1d5b8840d6088d6ba7ed4c_15338_180x180_fill_lanczos_center_3.png><meta name=theme-color content="#1565c0"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:site" content="@cbrueffer"><meta property="twitter:creator" content="@cbrueffer"><meta property="twitter:image" content="https://www.brueffer.io/publication/2020_asco/featured.webp"><meta property="og:site_name" content="Christian Brueffer"><meta property="og:url" content="https://www.brueffer.io/publication/2020_asco/"><meta property="og:title" content="Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492). | Christian Brueffer"><meta property="og:description" content="**Background**<br />
Breast cancer is a disease of genomic alterations, of which the complete panorama of somatic mutations and how these relate to molecular subtypes and therapy response is incompletely understood. The Sweden Cancerome Analysis Network-Breast project (SCAN-B; ClinicalTrials.gov NCT02306096) is a multi-center population-based ongoing prospective observational study elucidating the global transcriptomic profiles for thousands of patients and tumors using RNA sequencing. Since September 2010, over 15,000 patients with breast cancer have been enrolled at 9 hospitals across a wide geography of Sweden, comprising greater than 90% of all eligible patients in the catchment area.<br />
**Methods**<br />
Within SCAN-B, we developed an optimized bioinformatics pipeline for detection of single nucleotide variants and small insertions and deletions from RNA-seq data. From this, we describe the mutational landscape of 3,217 primary breast cancer transcriptomes, and relate it to patient overall survival in a real-world setting (median follow-up 75 months, range 2-105 months).<br />
**Results**<br />
We demonstrate that RNA-seq can be used to call mutations in important breast cancer genes such as *PIK3CA*, *TP53*, *ESR1*, and *ERBB2*, as well as mutation status of key molecular pathways and tumor mutational burden, identify mutations in one or more potentially druggable genes in 85.3% percent of cases, and reveal significant relationships to patient outcome within specific treatment groups. To make this rich and growing mutational portraiture of breast cancer available for the wider research community, we developed an open source interactive web application, SCAN-B MutationExplorer, publicly accessible at http://oncogenomics.bmc.lu.se/MutationExplorer.<br />
**Conclusions**<br /> These results add another dimension to the use of RNA-seq as a potential clinical tool, where both gene expression-based signatures and gene mutation-based biomarkers can be interrogated simultaneously and in real-time within one week of tumor sampling."><meta property="og:image" content="https://www.brueffer.io/publication/2020_asco/featured.webp"><meta property="og:locale" content="en-us"><meta property="article:published_time" content="2020-05-25T00:00:00+00:00"><meta property="article:modified_time" content="2020-05-25T00:00:00+00:00"><script type=application/ld+json>{"@context":"https://schema.org","@type":"Article","mainEntityOfPage":{"@type":"WebPage","@id":"https://www.brueffer.io/publication/2020_asco/"},"headline":"Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).","image":["https://www.brueffer.io/publication/2020_asco/featured.webp"],"datePublished":"2020-05-25T00:00:00Z","dateModified":"2020-05-25T00:00:00Z","author":{"@type":"Person","name":"Christian Brueffer"},"publisher":{"@type":"Organization","name":"Christian Brueffer","logo":{"@type":"ImageObject","url":"https://www.brueffer.io/media/icon_hu7422bdd1ad1d5b8840d6088d6ba7ed4c_15338_192x192_fill_lanczos_center_3.png"}},"description":"**Background**\u003cbr /\u003e\nBreast cancer is a disease of genomic alterations, of which the complete panorama of somatic mutations and how these relate to molecular subtypes and therapy response is incompletely understood. The Sweden Cancerome Analysis Network-Breast project (SCAN-B; ClinicalTrials.gov NCT02306096) is a multi-center population-based ongoing prospective observational study elucidating the global transcriptomic profiles for thousands of patients and tumors using RNA sequencing. Since September 2010, over 15,000 patients with breast cancer have been enrolled at 9 hospitals across a wide geography of Sweden, comprising greater than 90% of all eligible patients in the catchment area.\u003cbr /\u003e\n**Methods**\u003cbr /\u003e\nWithin SCAN-B, we developed an optimized bioinformatics pipeline for detection of single nucleotide variants and small insertions and deletions from RNA-seq data. From this, we describe the mutational landscape of 3,217 primary breast cancer transcriptomes, and relate it to patient overall survival in a real-world setting (median follow-up 75 months, range 2-105 months).\u003cbr /\u003e\n**Results**\u003cbr /\u003e\nWe demonstrate that RNA-seq can be used to call mutations in important breast cancer genes such as *PIK3CA*, *TP53*, *ESR1*, and *ERBB2*, as well as mutation status of key molecular pathways and tumor mutational burden, identify mutations in one or more potentially druggable genes in 85.3% percent of cases, and reveal significant relationships to patient outcome within specific treatment groups. To make this rich and growing mutational portraiture of breast cancer available for the wider research community, we developed an open source interactive web application, SCAN-B MutationExplorer, publicly accessible at http://oncogenomics.bmc.lu.se/MutationExplorer.\u003cbr /\u003e\n**Conclusions**\u003cbr /\u003e These results add another dimension to the use of RNA-seq as a potential clinical tool, where both gene expression-based signatures and gene mutation-based biomarkers can be interrogated simultaneously and in real-time within one week of tumor sampling."}</script><title>Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492). | Christian Brueffer</title></head><body id=top data-spy=scroll data-offset=70 data-target=#TableOfContents class=page-wrapper data-wc-page-id=749327f81fd1f3e35683b7be9402fef0><script src=/js/wowchemy-init.min.ec9d49ca50e4b80bdb08f0417a28ed84.js></script><aside class=search-modal id=search><div class=container><section class=search-header><div class="row no-gutters justify-content-between mb-3"><div class=col-6><h1>Search</h1></div><div class="col-6 col-search-close"><a class=js-search href=# aria-label=Close><i class="fas fa-times-circle text-muted" aria-hidden=true></i></a></div></div><div id=search-box><input name=q id=search-query placeholder=Search... autocapitalize=off autocomplete=off autocorrect=off spellcheck=false type=search class=form-control aria-label=Search...></div></section><section class=section-search-results><div id=search-hits></div></section></div></aside><div class="page-header header--fixed"><header><nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id=navbar-main><div class=container-xl><div class="d-none d-lg-inline-flex"><a class=navbar-brand href=/>Christian Brueffer</a></div><button type=button class=navbar-toggler data-toggle=collapse data-target=#navbar-content aria-controls=navbar-content aria-expanded=false aria-label="Toggle navigation">
<span><i class="fas fa-bars"></i></span></button><div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none"><a class=navbar-brand href=/>Christian Brueffer</a></div><div class="navbar-collapse main-menu-item collapse justify-content-start" id=navbar-content><ul class="navbar-nav d-md-inline-flex"><li class=nav-item><a class=nav-link href=/><span>About Me</span></a></li><li class=nav-item><a class=nav-link href=/#consulting><span>Consulting</span></a></li><li class=nav-item><a class=nav-link href=/#posts><span>Posts</span></a></li><li class=nav-item><a class=nav-link href=/#projects><span>Projects</span></a></li><li class=nav-item><a class=nav-link href=/#talks><span>Talks</span></a></li><li class="nav-item dropdown"><a href=# class="nav-link dropdown-toggle" data-toggle=dropdown aria-haspopup=true><span>Research</span><span class=caret></span></a><div class=dropdown-menu><a class=dropdown-item href=/#tags><span>Popular Topics</span></a>
<a class=dropdown-item href=/#featured><span>Featured Publications</span></a>
<a class=dropdown-item href=/#publications><span>Recent Publications</span></a>
<a class=dropdown-item href=/publication/><span>All Publications</span></a></div></li><li class=nav-item><a class=nav-link href=/#contact><span>Contact</span></a></li></ul></div><ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2"><li class=nav-item><a class="nav-link js-search" href=# aria-label=Search><i class="fas fa-search" aria-hidden=true></i></a></li><li class="nav-item dropdown theme-dropdown"><a href=# class=nav-link data-toggle=dropdown aria-haspopup=true aria-label="Display preferences"><i class="fas fa-moon" aria-hidden=true></i></a><div class=dropdown-menu><a href=# class="dropdown-item js-set-theme-light"><span>Light</span></a>
<a href=# class="dropdown-item js-set-theme-dark"><span>Dark</span></a>
<a href=# class="dropdown-item js-set-theme-auto"><span>Automatic</span></a></div></li></ul></div></nav></header></div><div class=page-body><div class=pub><div class="article-container pt-3"><h1>Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).</h1><div class=article-metadata><div><span class=author-highlighted>Christian Brueffer</span>, <span>Sergii Gladchuk</span>, <span>Christof Winter</span>, <span>Johan Vallon-Christersson</span>, <span>Cecilia Hegardt</span>, <span>Jari Häkkinen</span>, <span>Anthony M George</span>, <span>Yilun Chen</span>, <span>Anna Ehinger</span>, <span>Christer Larsson</span>, <span>Niklas Loman</span>, <span>Martin Malmberg</span>, <span>Lisa Rydén</span>, <span>Åke Borg</span>, <span>Lao H. Saal</span></div><span class=article-date>May, 2020</span></div><div class="btn-links mb-3"><a class="btn btn-outline-primary btn-page-header" href=https://doi.org/10.1200/JCO.2020.38.15_suppl.518 target=_blank rel=noopener>DOI</a></div></div><div class="article-header article-container featured-image-wrapper mt-4 mb-4" style=max-width:225px;max-height:301px><div style=position:relative><img src=/publication/2020_asco/featured_hu7cb39a094ac3074af1c1138febd7dc83_34864_720x2500_fit_q75_h2_lanczos_2.webp width=225 height=301 alt class=featured-image></div></div><div class=article-container><h3>Abstract</h3><p class=pub-abstract><strong>Background</strong><br>Breast cancer is a disease of genomic alterations, of which the complete panorama of somatic mutations and how these relate to molecular subtypes and therapy response is incompletely understood. The Sweden Cancerome Analysis Network-Breast project (SCAN-B; ClinicalTrials.gov NCT02306096) is a multi-center population-based ongoing prospective observational study elucidating the global transcriptomic profiles for thousands of patients and tumors using RNA sequencing. Since September 2010, over 15,000 patients with breast cancer have been enrolled at 9 hospitals across a wide geography of Sweden, comprising greater than 90% of all eligible patients in the catchment area.<br><strong>Methods</strong><br>Within SCAN-B, we developed an optimized bioinformatics pipeline for detection of single nucleotide variants and small insertions and deletions from RNA-seq data. From this, we describe the mutational landscape of 3,217 primary breast cancer transcriptomes, and relate it to patient overall survival in a real-world setting (median follow-up 75 months, range 2-105 months).<br><strong>Results</strong><br>We demonstrate that RNA-seq can be used to call mutations in important breast cancer genes such as <em>PIK3CA</em>, <em>TP53</em>, <em>ESR1</em>, and <em>ERBB2</em>, as well as mutation status of key molecular pathways and tumor mutational burden, identify mutations in one or more potentially druggable genes in 85.3% percent of cases, and reveal significant relationships to patient outcome within specific treatment groups. To make this rich and growing mutational portraiture of breast cancer available for the wider research community, we developed an open source interactive web application, SCAN-B MutationExplorer, publicly accessible at <a href=http://oncogenomics.bmc.lu.se/MutationExplorer target=_blank rel=noopener>http://oncogenomics.bmc.lu.se/MutationExplorer</a>.<br><strong>Conclusions</strong><br>These results add another dimension to the use of RNA-seq as a potential clinical tool, where both gene expression-based signatures and gene mutation-based biomarkers can be interrogated simultaneously and in real-time within one week of tumor sampling.</p><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Type</div><div class="col-12 col-md-9"><a href=/publication/#1>Conference paper</a></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Publication</div><div class="col-12 col-md-9"><em>Journal of Clinical Oncology, 2020. 38:15_suppl</em></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=space-below></div><div class=article-style><html><style>section{background:#fff;color:#000;border-radius:1em;padding:1em;left:50%}#inner{display:inline-block;display:flex;align-items:center;justify-content:center}</style><section><div id=inner><script type=text/javascript src=https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js></script>
<span style=float:left ; class=__dimensions_badge_embed__ data-doi=10.1200/JCO.2020.38.15_suppl.518 data-hide-zero-citations=true data-legend=always></span><script async src=https://badge.dimensions.ai/badge.js></script><div style=float:right ; data-link-target=_blank data-badge-details=right data-badge-type=medium-donut data-doi=10.1200/JCO.2020.38.15_suppl.518 data-condensed=true data-hide-no-mentions=true class=altmetric-embed></div></div></section></div><div class=article-tags><a class="badge badge-light" href=/tag/breast-cancer/>Breast Cancer</a>
<a class="badge badge-light" href=/tag/scan-b/>SCAN-B</a>
<a class="badge badge-light" href=/tag/rna-sequencing/>RNA Sequencing</a>
<a class="badge badge-light" href=/tag/open-source-software/>Open Source Software</a>
<a class="badge badge-light" href=/tag/phd/>PhD</a>
<a class="badge badge-light" href=/tag/bioinformatics/>Bioinformatics</a></div><div class=share-box><ul class=share><li><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2020_asco%2F&text=Defining+the+mutational+landscape+of+3%2C217+primary+breast+cancer+transcriptomes+through+large-scale+RNA-seq+within+the+Sweden+Cancerome+Analysis+Network%3A+Breast+Project+%28SCAN-B%3B+NCT03430492%29." target=_blank rel=noopener class=share-btn-twitter aria-label=twitter><i class="fab fa-twitter"></i></a></li><li><a href="https://www.facebook.com/sharer.php?u=https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2020_asco%2F&t=Defining+the+mutational+landscape+of+3%2C217+primary+breast+cancer+transcriptomes+through+large-scale+RNA-seq+within+the+Sweden+Cancerome+Analysis+Network%3A+Breast+Project+%28SCAN-B%3B+NCT03430492%29." target=_blank rel=noopener class=share-btn-facebook aria-label=facebook><i class="fab fa-facebook"></i></a></li><li><a href="mailto:?subject=Defining%20the%20mutational%20landscape%20of%203%2C217%20primary%20breast%20cancer%20transcriptomes%20through%20large-scale%20RNA-seq%20within%20the%20Sweden%20Cancerome%20Analysis%20Network%3A%20Breast%20Project%20%28SCAN-B%3B%20NCT03430492%29.&body=https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2020_asco%2F" target=_blank rel=noopener class=share-btn-email aria-label=envelope><i class="fas fa-envelope"></i></a></li><li><a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2020_asco%2F&title=Defining+the+mutational+landscape+of+3%2C217+primary+breast+cancer+transcriptomes+through+large-scale+RNA-seq+within+the+Sweden+Cancerome+Analysis+Network%3A+Breast+Project+%28SCAN-B%3B+NCT03430492%29." target=_blank rel=noopener class=share-btn-linkedin aria-label=linkedin-in><i class="fab fa-linkedin-in"></i></a></li><li><a href="https://web.whatsapp.com/send?text=Defining+the+mutational+landscape+of+3%2C217+primary+breast+cancer+transcriptomes+through+large-scale+RNA-seq+within+the+Sweden+Cancerome+Analysis+Network%3A+Breast+Project+%28SCAN-B%3B+NCT03430492%29.%20https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2020_asco%2F" target=_blank rel=noopener class=share-btn-whatsapp aria-label=whatsapp><i class="fab fa-whatsapp"></i></a></li><li><a href="https://service.weibo.com/share/share.php?url=https%3A%2F%2Fwww.brueffer.io%2Fpublication%2F2020_asco%2F&title=Defining+the+mutational+landscape+of+3%2C217+primary+breast+cancer+transcriptomes+through+large-scale+RNA-seq+within+the+Sweden+Cancerome+Analysis+Network%3A+Breast+Project+%28SCAN-B%3B+NCT03430492%29." target=_blank rel=noopener class=share-btn-weibo aria-label=weibo><i class="fab fa-weibo"></i></a></li></ul></div><div class="media author-card content-widget-hr"><a href=https://www.brueffer.io><img class="avatar mr-3 avatar-circle" src=/authors/cbrueffer/avatar_hu17f80c4ec327e7baf25f17a8159016b3_537581_270x270_fill_lanczos_center_3.png alt="Christian Brueffer"></a><div class=media-body><h5 class=card-title><a href=https://www.brueffer.io>Christian Brueffer</a></h5><h6 class=card-subtitle>Bioinformatician and Data Scientist</h6><p class=card-text>Freelance Bioinformatician and Data Scientist with interests including disease biology and diagnostics, particularly in cancer, and open source bioinformatics.</p><ul class=network-icon aria-hidden=true><li><a href=mailto:christian@brueffer.io><i class="fas fa-envelope"></i></a></li><li><a href=https://twitter.com/cbrueffer target=_blank rel=noopener><i class="fab fa-twitter"></i></a></li><li><a href=https://mastodon.social/@cbrueffer target=_blank rel=noopener><i class="fab fa-mastodon"></i></a></li><li><a href=https://www.linkedin.com/in/cbrueffer target=_blank rel=noopener><i class="fab fa-linkedin"></i></a></li><li><a href="https://scholar.google.com/citations?user=BFnR7W8AAAAJ" target=_blank rel=noopener><i class="ai ai-google-scholar"></i></a></li><li><a href=https://www.researchgate.net/profile/Christian_Brueffer2 target=_blank rel=noopener><i class="ai ai-researchgate"></i></a></li><li><a href=https://orcid.org/0000-0002-3826-0989 target=_blank rel=noopener><i class="ai ai-orcid"></i></a></li><li><a href=https://github.com/cbrueffer target=_blank rel=noopener><i class="fab fa-github"></i></a></li></ul></div></div></div></div></div><div class=page-footer><div class=container><footer class=site-footer><p class="powered-by copyright-license-text">© 2023 Christian Brueffer. This work is licensed under <a href=https://creativecommons.org/licenses/by-nc-nd/4.0 rel="noopener noreferrer" target=_blank>CC BY NC ND 4.0</a></p><p class="powered-by footer-license-icons"><a href=https://creativecommons.org/licenses/by-nc-nd/4.0 rel="noopener noreferrer" target=_blank aria-label="Creative Commons"><i class="fab fa-creative-commons fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-by fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-nc fa-2x" aria-hidden=true></i>
<i class="fab fa-creative-commons-nd fa-2x" aria-hidden=true></i></a></p><p class=powered-by>Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target=_blank rel=noopener>Wowchemy</a> — the free, <a href=https://github.com/wowchemy/wowchemy-hugo-themes target=_blank rel=noopener>open source</a> website builder that empowers creators.</p></footer></div></div><script src=/js/vendor-bundle.min.46271ef31da3f018e9cd1b59300aa265.js></script>
<script src=https://cdn.jsdelivr.net/npm/leaflet@1.7.1/dist/leaflet.min.js integrity crossorigin=anonymous></script>
<script id=search-hit-fuse-template type=text/x-template>
    <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
    </div>
  </script><script src=https://cdn.jsdelivr.net/gh/krisk/Fuse@v3.2.1/dist/fuse.min.js integrity="sha512-o38bmzBGX+hD3JHWUFCDA09btWaqrNmoJ3RXLlrysA7PP01Kgs4UlE4MhelE1v5dJR3+cxlR4qQlotsW7jKsnw==" crossorigin=anonymous></script>
<script src=https://cdn.jsdelivr.net/gh/julmot/mark.js@8.11.1/dist/jquery.mark.min.js integrity="sha512-mhbv5DqBMgrWL+32MmsDOt/OAvqr/cHimk6B8y/bx/xS88MVkYGPiVv2ixKVrkywF2qHplNRUvFsAHUdxZ3Krg==" crossorigin=anonymous></script>
<script id=page-data type=application/json>{"use_headroom":true}</script><script src=/js/wowchemy-headroom.db4755770454eb63685f8de785c0a172.js type=module></script>
<script src=/en/js/wowchemy.min.8621d706896ab6d11dd8fd7042e20931.js></script>
<script src=/js/wowchemy-map.a26e9d2f7238ba5b868384f1c5bc6477.js type=module></script><div id=modal class="modal fade" role=dialog><div class=modal-dialog><div class=modal-content><div class=modal-header><h5 class=modal-title>Cite</h5><button type=button class=close data-dismiss=modal aria-label=Close>
<span aria-hidden=true>&#215;</span></button></div><div class=modal-body><pre><code></code></pre></div><div class=modal-footer><a class="btn btn-outline-primary my-1 js-copy-cite" href=# target=_blank><i class="fas fa-copy"></i> Copy</a>
<a class="btn btn-outline-primary my-1 js-download-cite" href=# target=_blank><i class="fas fa-download"></i> Download</a><div id=modal-error></div></div></div></div></div><script src=/js/wowchemy-publication.68f8d7090562ca65fc6d3cb3f8f2d2cb.js type=module></script>
<script type=text/javascript src=https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js></script>
<script async src=https://badge.dimensions.ai/badge.js></script></body></html>